338 related articles for article (PubMed ID: 24840547)
1. Recent advances in Langerhans cell histiocytosis.
Morimoto A; Oh Y; Shioda Y; Kudo K; Imamura T
Pediatr Int; 2014 Aug; 56(4):451-61. PubMed ID: 24840547
[TBL] [Abstract][Full Text] [Related]
2. Langerhans cell histiocytosis and Erdheim-Chester disease.
Wilejto M; Abla O
Curr Opin Rheumatol; 2012 Jan; 24(1):90-6. PubMed ID: 22157416
[TBL] [Abstract][Full Text] [Related]
3. Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment.
Kobayashi M; Tojo A
Cancer Sci; 2018 Dec; 109(12):3707-3713. PubMed ID: 30281871
[TBL] [Abstract][Full Text] [Related]
4. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R
Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Treatment of Langerhans Cell Histiocytosis.
Monsereenusorn C; Rodriguez-Galindo C
Hematol Oncol Clin North Am; 2015 Oct; 29(5):853-73. PubMed ID: 26461147
[TBL] [Abstract][Full Text] [Related]
6. Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?
Garabedian L; Struyf S; Opdenakker G; Sozzani S; Van Damme J; Laureys G
Eur Cytokine Netw; 2011 Sep; 22(3):148-53. PubMed ID: 22001902
[TBL] [Abstract][Full Text] [Related]
7. Langerhans cell histiocytosis.
Ladisch S
Curr Opin Hematol; 1998 Jan; 5(1):54-8. PubMed ID: 9515204
[TBL] [Abstract][Full Text] [Related]
8. [Langerhans cell histiocytosis in adults].
Néel A; Artifoni M; Donadieu J; Lorillon G; Hamidou M; Tazi A
Rev Med Interne; 2015 Oct; 36(10):658-67. PubMed ID: 26150351
[TBL] [Abstract][Full Text] [Related]
9. Langerhans cell histiocytosis in children: from the bench to bedside for an updated therapy.
Aricò M
Br J Haematol; 2016 Jun; 173(5):663-70. PubMed ID: 26913480
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory serum cytokines and chemokines increase associated with the disease extent in pediatric Langerhans cell histiocytosis.
Morimoto A; Oh Y; Nakamura S; Shioda Y; Hayase T; Imamura T; Kudo K; Imashuku S;
Cytokine; 2017 Sep; 97():73-79. PubMed ID: 28582647
[TBL] [Abstract][Full Text] [Related]
11. Langerhans cell histiocytosis: a review of past, current and future therapies.
Allen CE; McClain KL
Drugs Today (Barc); 2007 Sep; 43(9):627-43. PubMed ID: 17940639
[TBL] [Abstract][Full Text] [Related]
12. [Pathophysiology and treatment of adult Langerhans cell histiocytosis].
Tojo A; Kobayashi M
Rinsho Ketsueki; 2020; 61(9):1028-1034. PubMed ID: 33162496
[TBL] [Abstract][Full Text] [Related]
13. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
14. Differentiating skin-limited and multisystem Langerhans cell histiocytosis.
Simko SJ; Garmezy B; Abhyankar H; Lupo PJ; Chakraborty R; Lim KP; Shih A; Hicks MJ; Wright TS; Levy ML; McClain KL; Allen CE
J Pediatr; 2014 Nov; 165(5):990-6. PubMed ID: 25441388
[TBL] [Abstract][Full Text] [Related]
15. Craniofacial involvement in Langerhans cell histiocytosis: A review of 44 cases at a single medical center.
Lin TE; Chu YY; Chang TY; Liao HT
J Plast Reconstr Aesthet Surg; 2023 Jul; 82():12-20. PubMed ID: 37148805
[TBL] [Abstract][Full Text] [Related]
16. Langerhans cell histiocytosis: Current concepts and treatments.
Abla O; Egeler RM; Weitzman S
Cancer Treat Rev; 2010 Jun; 36(4):354-9. PubMed ID: 20188480
[TBL] [Abstract][Full Text] [Related]
17. Activated Conventional T-Cells Are Present in Langerhans Cell Histiocytosis Lesions Despite the Presence of Immune Suppressive Cytokines.
Quispel WT; Stegehuis-Kamp JA; Santos SJ; Egeler RM; van Halteren AG
J Interferon Cytokine Res; 2015 Oct; 35(10):831-9. PubMed ID: 26381039
[TBL] [Abstract][Full Text] [Related]
18. [Langerhans cell histiocytosis in adults].
Nquyen K; Tazi A
Rev Prat; 2006 Nov; 56(17):1863-71. PubMed ID: 17243381
[TBL] [Abstract][Full Text] [Related]
19. High dose immunoglobulin (IVIG) may reduce the incidence of Langerhans cell histiocytosis (LCH)-associated central nervous system involvement.
Imashuku S
CNS Neurol Disord Drug Targets; 2009 Nov; 8(5):380-6. PubMed ID: 19702569
[TBL] [Abstract][Full Text] [Related]
20. Langerhans cell histiocytosis of the orbit: a need for interdisciplinary dialogue.
Harris GJ
Am J Ophthalmol; 2006 Feb; 141(2):374-378. PubMed ID: 16458699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
